04 January 2019 3 8K Report

Despite the good effectivity of the immune checkpoint inhibitors a proportion of patients will face relapse, and will be resistant to this treatment.

I am intereseted if we know anything about the genetics of this mechanism.

More Akos Nagy's questions See All
Similar questions and discussions